Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Interest Expense : ¥-6.1 Mil (TTM As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Shapuaisi Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Zhejiang Shapuaisi Pharmaceutical Co's interest expense for the three months ended in Sep. 2024 was ¥ -2.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-6.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Zhejiang Shapuaisi Pharmaceutical Co's Operating Income for the three months ended in Sep. 2024 was ¥ -17.1 Mil. Zhejiang Shapuaisi Pharmaceutical Co's Interest Expense for the three months ended in Sep. 2024 was ¥ -2.3 Mil. Zhejiang Shapuaisi Pharmaceutical Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zhejiang Shapuaisi Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Zhejiang Shapuaisi Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shapuaisi Pharmaceutical Co Interest Expense Chart

Zhejiang Shapuaisi Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.03

-0.19

-0.77

-1.64

-2.60

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial															-1.27	-0.02	-1.21	-2.54	-2.30

Zhejiang Shapuaisi Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-6.1 Mil.

Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zhejiang Shapuaisi Pharmaceutical Co's Interest Expense for the three months ended in Sep. 2024 was ¥-2.3 Mil. Its Operating Income for the three months ended in Sep. 2024 was ¥-17.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was ¥123.4 Mil.

Zhejiang Shapuaisi Pharmaceutical Co's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Zhejiang Shapuaisi Pharmaceutical Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Zhejiang Shapuaisi Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shapuaisi Pharmaceutical Co Ltd (SHSE:603168) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200

Website

https://www.zjspas.com

Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.

Executives

Huang Ming Xiong	Directors, senior managers
Wu Jian Guo	Director
Xu Hong Sheng	senior management
Hu Zheng Guo	Director
Ge Sheng Fang	Director
Feng Xiao	Supervisors
Chen De Kang	Director

Zhejiang Shapuaisi Pharmaceutical Co Headlines

No Headlines